HS
RXDX
HighVista Strategies’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,955
| Closed | -$2.25M | – | 162 |
|
|
2023
Q1 | $2.25M | Buy |
20,955
+1,679
| +9% | +$180K | 1.83% | 20 |
|
|
2022
Q4 | $2.12M | Buy |
19,276
+11,445
| +146% | +$1.26M | 1.26% | 24 |
|
|
2022
Q3 | $462K | Sell |
7,831
-2,951
| -27% | -$174K | 0.26% | 83 |
|
|
2022
Q2 | $304K | Buy |
+10,782
| New | +$304K | 0.18% | 93 |
|